2seventy bio, Inc (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Ex-Eisai leader Ivan Cheung to be new NextPoint CEO—Chutes & Ladders fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
By Colin Kellaher 2seventy bio has agreed to sell its research-and-development pipeline to Regeneron Pharmaceuticals as part of a pivot by the biotechnology company to focus exclusively on the.
- Company to focus exclusively on commercialization and development of Abecma, in partnership with Bristol Myers Squibb -
- Company to sell R&D pipeline to Regeneron to launch Regeneron Cell.
2seventy Sells Cell Therapy Operations to Regeneron, in Latest Restructuring genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.